Remedy has not only worked traditionally on one game at a time, it’s often been wedded to a single platform, part-funded by the platform holder. Does the change in studio structure mean a change in that approach too? “Of course, as a creative company, you want to reach as big an audience as possible,” Puha says. “So you want to be out on as many platforms as you can. But when you’re exclusive to one or two platforms, or almost a firstparty game like we were with Microsoft [for
QuantumBreak], there are a lot of benefits. There are a lot of opportunities these days for independent developers to get funding. It’s a complicated space, sure, but with a lot of opportunities.” Remedy isn’t saying much about its two current projects, but we do know it’s trying something different on one of them, signing up with a publisher it’s never worked with before. Thirteen years on from MaxPayne2, could Remedy finally return to PlayStation?